Guardant Health (GH) Cash from Investing Activities Growth (3y) (2020 - 2026)
Guardant Health (GH) Cash from Investing Activities Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 33.33% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -188.86% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 2.46% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 0.00% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 13.86% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -59.07% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -48.84% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 64.36% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 41.86% |
| 10 | Guardant Health | 21.59 Bn | 20.53 Bn | 219.03 Mn | 34.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 34.27% |
| Mar 31, 2026 | 64.46% |
| Dec 31, 2025 | -145.60% |
| Sep 30, 2025 | -32.91% |
| Jun 30, 2025 | 47.33% |
| Mar 31, 2025 | 39.82% |
| Dec 31, 2024 | 26.82% |
| Sep 30, 2024 | -83.91% |
| Jun 30, 2024 | -26.83% |
| Mar 31, 2024 | -39.04% |
| Dec 31, 2023 | 61.71% |
| Sep 30, 2023 | 170.48% |
| Jun 30, 2023 | 9.52% |
| Mar 31, 2023 | 96.24% |
| Dec 31, 2022 | 44.60% |
| Sep 30, 2022 | 46.67% |
| Jun 30, 2022 | 38.96% |
| Mar 31, 2022 | 93.35% |
| Dec 31, 2021 | -10.50% |
| Sep 30, 2021 | -57.91% |